Raily Aesthetic Medicine Schedules Board Meeting for Interim Results
I'm PortAI, I can summarize articles.
Raily Aesthetic Medicine International Holdings Limited (HK:2135) has scheduled a board meeting for August 29, 2025, to approve its unaudited interim results for the first half of 2025 and discuss potential dividend declarations. This meeting will impact the company's financial disclosures and shareholder returns. The company operates in the aesthetic medicine industry and is listed on the Hong Kong Stock Exchange, with a current market cap of HK$69.63M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments